Cite
HARVARD Citation
Nugteren, S. et al. (n.d.). P064 High intestinal Secretory Leukocyte Protease Inhibitor (SLPI) expression correlates with abundant neutrophilic inflammation and identifies Inflammatory Bowel Disease patients with a strong IL-17 response. Journal of Crohn's and colitis. pp. i232-i233. [Online].